The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Open accessAbstract
Dopamine is a neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dysfunction of the dopamine system has been implicated in different nervous system diseases. The level of dopamine transmission increases in response to any type of reward and by a large number of strongly additive drugs. The role of dopamine dysfunction as a consequence of oxidative stress is involved in health and disease. Introduce new potential targets for the development of therapeutic interventions based on antioxidant compounds. The present review focuses on the therapeutic potential of antioxidant compounds as a coadjuvant treatment to conventional neurological disorders is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
Schultz, W., Apicella, P., & Ljungberg, T. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-00900.1993 · Cited by 1,291
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Calabresi, P., Picconi, B., Tozzi, A., & Di Filippo, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.001 · Cited by 865
The control of firing pattern in nigral dopamine neurons: single spike firing
Grace, A., & Bunney, B. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02866.1984 · Cited by 858
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 370
Chapter 19 The determinants of stress-induced activation of the prefrontal cortical dopamine system
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62691-6 · Cited by 364
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
The genetics and evo–devo of butterfly wing patterns
Beldade, P., & Brakefield, P. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg818 · Cited by 333
Selective D2 receptor actions on the functional circuitry of working memory
Wang, M., Vijayraghavan, S., & Goldman-Rakic, P. S. (2004) · Science · doi:10.1126/science.1091162 · Cited by 319
The role of maternal obesity in the risk of neuropsychiatric disorders
Rivera, H. M., Christiansen, K. J., & Sullivan, E. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00194 · Cited by 307
Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis
Wu, J., Xiao, H., Sun, H., Zou, L., & Zhu, L.-Q. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8278-5 · Cited by 274
Mansouri, M. T., Farbood, Y., Sameri, M. J., Sarkaki, A., Naghizadeh, B., & Rafeirad, M. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.022 · Cited by 255
Feeding behavior in dopamine-deficient mice
Szczypka, M. S., Rainey, M. A., Kim, D. S., Alaynick, W. A., Marck, B. T., Matsumoto, A. M., & Palmiter, R. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12138 · Cited by 242
Clarke, J. R., Lyra e Silva, N. M., Figueiredo, C. P., Frozza, R. L., Ledo, J. H., Beckman, D., Katashima, C. K., Razolli, D., Carvalho, B. M., Frazão, R., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404183 · Cited by 214
The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212
The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
Abi-Saab, W., D'Souza, D., Moghaddam, B., & Krystal, J. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979354 · Cited by 208
Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis
Gorter, J. A., van Vliet, E. A., & Aronica, E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.047 · Cited by 194
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
Müller, T. (2015) · Drugs · doi:10.1007/s40265-014-0343-0 · Cited by 190
Antioxidants as Antidepressants: Fact or Fiction?
Scapagnini, G., Davinelli, S., Drago, F., De Lorenzo, A., & Oriani, G. (2012) · CNS Drugs · doi:10.2165/11633190-000000000-00000 · Cited by 182
NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease
Choi, D.-H., Cristóvão, A. C., Guhathakurta, S., Lee, J., Joh, T. H., Beal, M. F., & Kim, Y.-S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3960 · Cited by 178
Newman‐Tancredi, A., & Kleven, M. S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2247-y · Cited by 174
Huang, J. H., Zhong, Z., Wang, M., Chen, X., Tan, Y., Zhang, S., He, W., He, X., Huang, G., Lu, H., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2551-14.2015 · Cited by 172
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Tabrez, S. S. M., Jabir, N. R., Shakil, S., Greig, N. H., Alam, Q., Abuzenadah, A. M., Damanhouri, G., & Kamal, M. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792785 · Cited by 168
Amphetamine Paradoxically Augments Exocytotic Dopamine Release and Phasic Dopamine Signals
Daberkow, D. P., Brown, H. D., Bunner, K. D., Kraniotis, S. A., Doellman, M. A., Ragozzino, M. E., Garris, P. A., & Roitman, M. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2136-12.2013 · Cited by 165
Antunes, M. S., Goes, A. T. R., Boeira, S. P., Prigol, M., & Jesse, C. R. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.024 · Cited by 161
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160
Shi, J., Johansson, J. U., Woodling, N. S., Wang, Q., Montine, T. J., & Andreasson, K. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903487 · Cited by 159
Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., Mitchell, S. L., & Zhang, W. (2014) · The FASEB Journal · doi:10.1096/fj.14-252874 · Cited by 149
Dietary bioactive peptides: Human studies
Bouglé, D. L., & Bouhallab, S. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.873766 · Cited by 144
Cytochrome P450–mediated drug metabolism in the brain
Miksys, S. L., & Tyndale, R. F. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120133 · Cited by 141
Hatami, A., Albay, R., Monjazeb, S., Milton, S. C. F., & Glabe, C. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594846 · Cited by 125
Schmitt, K. C., Rothman, R. B., & Reith, M. E. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191056 · Cited by 121
Wu, C., Tsai, C.-W., Chang, S., Lin, C., Huang, L., & Tsai, C.-W. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.11.011 · Cited by 117
Youdim, M. B. H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.1 · Cited by 113
Pathological dynamics of activated microglia following medial forebrain bundle transection
Cho, B. P., Song, D., Sugama, S., Shin, D. H., Shimizu, Y., Kim, S. S., Kim, Y. S., & JOH, T. H. (2005) · Glia · doi:10.1002/glia.20265 · Cited by 107
Liu, H., Mao, P., Wang, J., Wang, T., & Xie, C.-H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430271 · Cited by 102
Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease
Shi, J., Wang, Q., Johansson, J. U., Liang, X., Woodling, N. S., Priyam, P. G., Loui, T., Merchant, M. J., BREYER, R. M., Montine, T. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23677 · Cited by 99
Barbiero, J. K., Santiago, R. M., Tonin, F. S., Boschen, S. L., da Silva, L. M., Werner, M. F. D. P., Cunha, C. D., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.009 · Cited by 97
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system
Patriquin, M. A., Bauer, I. E., Soares, J. C., Graham, D. P., & Nielsen, D. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000095 · Cited by 97
Cheng, M. H., Block, E. R., Hu, F., Çobanoğlu, M. C., Sorkin, A. D., & Bahar, İ. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00134 · Cited by 89
Spanos, M., Gras-Najjar, J., Letchworth, J. M., Sanford, A. L., Toups, J. V., & Sombers, L. A. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4000499 · Cited by 84
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
Macchi, B., Paola, R. D., Marino‐Merlo, F., Felice, M. R., Cuzzocrea, S., & Mastino, A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150225124928 · Cited by 82
Changes in Selenoprotein P in Substantia Nigra and Putamen in Parkinson's Disease
Bellinger, F. P., Raman, A. V., Rueli, R. H., Bellinger, M. T., Dewing, A. S. T., Seale, L. A., Andres, M. A., Uyehara‐Lock, J. H., White, L. R., Ross, G. W., et al. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-11052 · Cited by 79
Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry
Kato, T. A., Yamauchi, Y., Horikawa, H., Monji, A., Mizoguchi, Y., Seki, Y., Hayakawa, K., Utsumi, H., & Kanba, S. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320030003 · Cited by 78
Gaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 77
Liu, S., Li, X., Huo, Y., & Lü, F. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.02.006 · Cited by 77
Chiu, V. M., & Schenk, J. O. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205030227 · Cited by 75
Ning, X., Guo, Y. Q., Wang, X., Ma, X., Tian, C., Shi, X., Zhu, R., Cheng, C., Du, Y., Ma, Z., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500258v · Cited by 69
Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity
McCormick, A. V., Wheeler, J. M., Guthrie, C. R., Liachko, N. F., & Kraemer, B. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.027 · Cited by 65
The role of connexin‐36 gap junctions in alcohol intoxication and consumption
Steffensen, S. C., Bradley, K. D., Hansen, D. M., Wilcox, J. D., Wilcox, R. S., Allison, D. W., Merrill, C. B., & Edwards, J. G. (2010) · Synapse · doi:10.1002/syn.20885 · Cited by 60
Slaney, T. R., Mabrouk, O. S., Porter‐Stransky, K. A., Aragona, B. J., & Kennedy, R. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300158p · Cited by 59
Lin, C., Chen, J., Fu, R., & Tsai, C.-W. (2014) · Chemical Research in Toxicology · doi:10.1021/tx5003063 · Cited by 58
DNA Repair Genes in Parkinson's Disease
Gençer, M., Daşdemir, S., Çakmakoğlu, B., Çetinkaya, Y., Varlıbaş, F., Tireli, H., Küçükali, C. İ., Özkök, E., & Aydın, M. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0252 · Cited by 51
Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.
Labandeira-García, J. L., Rodríguez‐Pallares, J., Villar‐Cheda, B., Rodriguez-Perez, A. I., Garrido‐Gil, P., & Guerra, M. J. (2011) · Europe PMC (PubMed Central) · Cited by 50
Zhang, Y., Granholm, A.-C., Huh, K. H., Shan, L., Díaz-Ruiz, O., Malik, N., Olson, L., Hoffer, B. J., Lupica, C. R., Hoffman, A. F., et al. (2012) · Brain · doi:10.1093/brain/aws196 · Cited by 47
Inden, M., Kitamura, Y., Takahashi, K., Takata, K., Ito, N., Niwa, R., Funayama, R., Nishimura, K., Taniguchi, T., Honda, T., et al. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11151fp · Cited by 46
Guo, B., Xu, D., Duan, H., Du, J., Zhang, Z., Lee, S. M., & Wang, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00743 · Cited by 44
Lambert, M., SCHIMMELMANN, B. G., Karow, A., & Naber, D. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45128 · Cited by 43
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis
Ferreira, T. B., Barros, P. O., Teixeira, B., Cassano, T., Centurião, N., Kasahara, T. M., Hygino, J., Vasconcelos, C. C. F., Filho, H. A., Alvarenga, R. M. P., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.013 · Cited by 41
Borah, A., & Mohanakumar, K. P. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.05.008 · Cited by 40
Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum
Tokunaga, N., Choudhury, M. E., Nishikawa, N., Nagai, M., Tujii, T., Iwaki, H., Kaneta, M., & Nomoto, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12096sc · Cited by 39
Jung, Y.-H., Kang, D., Byun, M. S., Shim, G., Kwon, J. S., Jang, G.-E., Lee, U. S., An, S. C., Jang, J. H., & Kwon, J. S. (2011) · Stress · doi:10.3109/10253890.2011.592880 · Cited by 38
Henze, C., Earl, C. D., Sautter, J., Schmidt, N., Themann, C., Hartmann, A., & Oertel, W. H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.020 · Cited by 38
Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.
Labandeira-García, J. L., Rodríguez‐Pallares, J., Rodriguez-Perez, A. I., Garrido‐Gil, P., Villar‐Cheda, B., Valenzuela, R., & Guerra, M. J. (2012) · Europe PMC (PubMed Central) · Cited by 37
Schizophrenia, Psychosis, and Cerebral Spinal Fluid Homovanillic Acid Concentrations
Maas, J. W., Bowden, C. L., Miller, A. L., Javors, M. A., Funderburg, L. G., Berman, N., & Weintraub, S. T. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.1.147 · Cited by 37
Minelli, A., Conte, C., Cacciatore, I., Cornacchia, C., & Pinnen, F. (2012) · Amino Acids · doi:10.1007/s00726-011-1210-x · Cited by 36
Brain Region Specific Monoamine and Oxidative Changes During Restraint Stress
Ahmad, A., Rasheed, N., Ashraf, G. M., Kumar, R., Banu, N., Khan, F., Al-Sheeha, M., & Palit, G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013433 · Cited by 36
Mousseau, D., & Baker, G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805219969 · Cited by 35
The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
Tolleson, C., & Claassen, D. O. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792794 · Cited by 34
St�rung des Tyrosin- und Tryptophanmetabolismus bei Depression
Birkmayer, W., & Linauer, W. (1970) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00341554 · Cited by 32
Scheggi, S., Pelliccia, T., Ferrari, A., Montis, M. G. D., & Gambarana, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.006 · Cited by 32
Antala, B., Patel, M., Bhuva, S., Gupta, S., Rabadiya, S., & Lahkar, M. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.103242 · Cited by 32
On mechanism of superoxide signaling under physiological and pathophysiological conditions
Afanasʹev, I. B. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.05.009 · Cited by 32
NOX Inhibitors as a Therapeutic Strategy for Stroke and Neurodegenerative Disease
Cairns, B., Kim, J. Y., Tang, X. N., & Yenari, M. A. (2012) · Current Drug Targets · doi:10.2174/138945012799201676 · Cited by 31
Chronic cocaine disrupts mesocortical learning mechanisms
Buchta, W. C., & Riegel, A. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.003 · Cited by 30
Borah, A., Paul, R. K., Mazumder, M. K., & Bhattacharjee, N. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1330-2 · Cited by 29
Tarazi, F. I., & Neill, J. C. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.738193 · Cited by 28
Santra, S., Xu, L., Shah, M. M., Johnson, M., & Dutta, A. K. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400106n · Cited by 28
Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders
Yamaguchi, Y., Lee, Y., & Goto, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00219 · Cited by 27
Berglund, E. C., Makos, M. A., Keighron, J. D., Phan, N. T. N., Heien, M. L., & Ewing, A. G. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002009 · Cited by 26
Mocchetti, I., Bachis, A., Nosheny, R. L., & Tanda, G. (2007) · Neurotoxicity Research · doi:10.1007/bf03033922 · Cited by 26
Deslauriers, J., Desmarais, C., Sarret, P., & Grignon, S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9884-4 · Cited by 25
Han, X., Cheng, M.-N., Chen, L., Fang, H., Wang, L.-J., Li, X., & Qu, Z. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.08.016 · Cited by 23
Barr, J. L., Deliu, E., Brailoiu, G. C., Zhao, P., Yan, G., Abood, M. E., Unterwald, E. M., & Brailoiu, E. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.05.001 · Cited by 22
Ferris, M. J., Calipari, E. S., Rose, J. H., Siciliano, C. A., Sun, H., Chen, R., & Jones, S. R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.45 · Cited by 21
Reynolds-May, M. F., Kenna, H. A., Marsh, W., Stemmle, P. G., Wang, P. W., Ketter, T. A., & Rasgon, N. (2013) · Bipolar Disorders · doi:10.1111/bdi.12149 · Cited by 19
Tan, M. L., Basu, D., Kwiecień, J. M., Johnson, R. L., & Mishra, R. K. (2013) · Peptides · doi:10.1016/j.peptides.2013.02.004 · Cited by 17
Li, Z., Wang, H., Ba, Y., et al. (2014) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20140923 · Cited by 17
Saint-Preux, F., Bores, L. R., Tulloch, I., Ladenheim, B., Kim, R., Thanos, P. K., Volkow, N. D., & Cadet, J. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.052 · Cited by 16
Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels
López‐Pérez, S. J., Morales‐Villagrán, A., & Medina‐Ceja, L. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0117-3 · Cited by 16
Axon Guidance in the Dopamine System
Prasad, A. A., & Pasterkamp, R. J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0322-8_9 · Cited by 14
Nakaoka, H., Mogi, M., Kan‐no, H., Tsukuda, K., Ohshima, K., Wang, X., Chisaka, T., Bai, H., Shan, B., Kukida, M., et al. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315573680 · Cited by 13
Rieker, C., Schober, A., Bilbao, A., Schütz, G., & Parkitna, J. M. R. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08003.x · Cited by 12
Matveychuk, D., Nunes, E. A., Ullah, N., Velázquez‐Martínez, C. A., MacKenzie, E. M., & Baker, G. B. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0978-0 · Cited by 12
A New VMAT ‐2 Inhibitor NBI ‐641449 in the Treatment of Huntington Disease
Chen, S., Zhang, X., Xie, W., Qiu, H., Liu, H., & Le, W. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12425 · Cited by 12
Bridging between transplantation therapy and neurotrophic factors in Parkinson s disease
Smith, G. M. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e704 · Cited by 11
In Vitro Screening of Psychoactive Drugs to Prevent the Abuses
Satoh, K., & Nonaka, R. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.1771 · Cited by 4
Cited by
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482
Leyane, T. S., Jere, S. W., & Houreld, N. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137273 · Cited by 469
Dopamine in Parkinson's disease
Latif, S., Jahangeer, M., Maknoon Razia, D., Ashiq, M., Ghaffar, A., Akram, M., El Allam, A., Bouyahya, A., Garipova, L., Ali Shariati, M., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 340
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Metadata
- Authors
- Juárez Olguín, H., Calderón Guzmán, D., Hernández García, E., & Barragán Mejía, G.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2015-12-06
- Volume
- 2016
- Issue
- 1
- Pages
- 9730467-9730467
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W1764815628
- Cited by
- 462
- References
- 100
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.